Gynecomastia and sexual impotence associated with methotrexate treatment.
Methotrexate (MTX) is the disease modifying antirheumatic drug most frequently used for rheumatoid and psoriatic arthritis (PsA). Several reports associate sexual dysfunction to MTX use. We describe 2 cases of sexual impotence and gynecomastia in patients with PsA treated with MTX. Although the mechanism underlying MTX induced sexual dysfunction is unknown, the potential consequences should be taken in account in view of the steady increase in the number of patients.
Aguirre
Maria Angeles
MA
Servicio Reumatologia, Hospital Universitario Reina Sofía, Universidad de Córdoba, Spain. angelesaguirre@supercable.es
Vélez
Antonio
A
Romero
Manuel
M
Collantes
Eduardo
E
D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects*; D015535:Arthritis, Psoriatic / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D007172:Erectile Dysfunction / Q000209:etiology* / Q000473:pathology; D006177:Gynecomastia / Q000209:etiology* / Q000473:pathology; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*
D018501:Antirheumatic Agents; D008727:Methotrexate